GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S 23, HR 1249 America Invents Act - provisions related to supplemental examination, first inventor to file, best mode, and false marking S 27 Preserve Access to Affordable Generics Act - provisions related to patent settlements HR 1056 Patent Continuing Disclosure Act - provisions related to false patent marking HR 243, S 515 Patent Lawsuit Reform Act of 2011 - provisions related to false patent marking
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Health Issues HCR
PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions HR 1930 Access to Appropriate Immunizations for Veterans Act of 2011- extending VA performance measures to include all federally recommended vaccines HR 2405Pandemic and All Hazards Preparedness Act - re-authorization; influenza vaccine innovative technologies S 1002 Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES) - drug safety HR 1483The Drug Safety Enhancement Act of 2011- drug safety standards HR 2182Generating Antibiotic Incentives Now Act of 2011- provisions related to antibiotics and incentives HR 1930Access to Appropriate Immunizations for Veterans Act of 2011- vaccine access HR 3202Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment S 3397Secure and Responsible Drug Disposal Act - provisions related to safe drug disposal S 319 Pharmaceutical Market Access and Drug Safety Act of 2011- provisions related to drug importation HR 2245Preserving Access to Life-Savings Medicines Act of 2011- provisions related to drug shortages HR 2939Pharmaceutical Stewardship Act of 2011- provisions related to drug safety S 1584The Drug Safety and Accountability Act of 2011- provisions related to drug safety HR 2529, S 1368 Restoring Access to Medication Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts HR 605, S 312 Patients Freedom to Choose Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts ADDENDUM/General Lobbying Issue Area - Federal Food, Drug, and Cosmetic Act (currently unassigned) - section related to FDA and regulation of nicotine replacement therapies ADDENDUM/General Lobbying Issue Area - Prescription Drug User Fee Act (currently unassigned) - issues related to reauthorization of the Prescription Drug User Fee Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Medicare/Medicaid MMM
HR 999 Medicare Prescription Drug Savings and Choice Act of 2011- provisions related to Medicare Part D HR 2190 Medicare Drug Savings Act of 2011- provisions related to Medicare Part D HR 2248 Medicare Prescription Drug Price Negotiation Act of 2011 - provision related to Medicare Part D S 31 Prescription Drug and Health Improvement Act of 2011 - provisions related to Medicare Part D S 44 Medicare Prescription Drug Price Negotiation Act of 2011- provisions related to Medicare Part D HR 452 Medicare Decisions Accountability Act - provisions related to the Independent Payment Advisory Board (IPAB) S 365 Budget Control Act of 2011- deficit reduction issues related to Medicare and Medicaid S 560 Medicare Prescription Drug Savings and Choice Act of 2011- provisions related to Medicare Part D S 668 Health Care Bureaucrats Elimination Act - provisions related to the Independent Payment Advisory Board (IPAB) S 1206 Medicare Prescription Drug Savings Act of 2011- provisions related to Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Budget/Appropriations BUD
HR 2112 Fiscal Year 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act - provisions pertaining to Ryan White CARE Act, FDA funding HR 2017 The Department of Homeland Security Appropriations Act - provisions pertaining to Customs and Border Protection S 1599 Fiscal Year 2012 Labor - HHS-Education Appropriations -FY 2012 HHS Budget Request; proposal relating to Vaccine Section 317 program, Ryan White CARE Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.